genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Ligand Pharmaceuticals
News
Ligand Licenses Lipid Technology to Omthera in Up to $44.5M Deal
Drug Discovery
Ligand, CURx Make $21M Injectable Epilepsy Drug Deal
News
Ligand Inks Week’s Second Lasofoxifene Licensing Deal
News
Azure Nabs Rights to Ligand Lasofoxifene Formulation
News
Ligand Buys Potential Milestone/Royalty Portfolio in Up To $4.5M Deal
Insights
Using Microbes to Improve Polymer Beads
News
Trevena Scores $10M NIH Grant to Develop a Drug for Depression
Bioprocessing
PhyNexus and BAC Combine Technologies for Small-Volume Protein Purification
Industry News
Ligand to Pay $35.5M for CyDex Pharmaceuticals
News
Proximagen Gains Compound Hits for CXCR4 Target from Ligand Pharmaceuticals
1
2
3
4
Page 2 of 4
Scroll Up
Scroll Up
